William T Abraham MD FACP, FACC, FAHA, FESC, FRCPE

Summary

• William T. Abraham, MD is Professor of Internal Medicine and College of Medicine Distinguished Professor at The Ohio State University. Dr. Abraham earned his medical degree from Harvard Medical School, following which he completed residency in Internal Medicine and fellowships in Cardiovascular Diseases and Advanced Heart Failure/Transplant Cardiology at the University of Colorado. At Ohio State, Dr. Abraham has held several leadership positions including Associate Dean for Clinical and Translational Research and Division Director for Cardiovascular Medicine. Dr. Abraham spends the majority of his clinical time managing heart failure patients. He has been recognized as one of the “Best Doctors in America” for twenty consecutive years and has been ranked among the top 10% of physicians nationally in patient satisfaction. Dr. Abraham has received grants from the National Institutes of Health, including more than $11 million in NIH funding over the past 5 years, and has served as national or international PI and on the Executive or Steering Committees of numerous clinical drug and device trials. He has participated in all regulatory phases of new drug and device development from pre-clinical evaluation to Pre-Market Approval and New Drug Application submission and approval. His work has resulted in approval/adoption of new therapies for heart failure, including beta-blockers, cardiac resynchronization therapy, ultrafiltration, implantable hemodynamic monitors, cardiac contractility modulation, transcatheter mitral valve repair, and baroreflex activation therapy. Dr. Abraham has authored more than 1,500 original papers, abstracts, book chapters, and review articles. He has been named to the Clarivate Analytics Highly Cited Researchers list and as one of The World's Most Influential Scientific Minds. He has received the Distinguished Scientist Award from the American College of Cardiology and the Pioneer Award from the Heart Failure Society of America.